Ginkgo Bioworks Holdings, Inc.
DNA
Jodie situation report
Ginkgo Bioworks Holdings, Inc.'s move is spreading beyond its market group.
No new filing conclusion is available. 5 of 8 group members are active now; 1 filing-linked outsider is moving with the group, and 0 of 2 directly disclosed connections are confirming.
- Participation spreads to CLNN, PACB, VERU.
- Capital-flow agreement rises above 55%.
- TXG remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 2 of 8 members or fewer.
Who this business touches
The relationships behind DNA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
SYBXFiling-linked namepartnerNov 6, 2025 ▾
“Our transactions with Genomatica and Synlogic included the purchase of equity securities and the provision of R&D services.”
SYBXFiling-linked nameinvesteeAug 7, 2025 ▾
“Our transactions with Genomatica and Synlogic included the purchase of equity securities and the provision of R&D services.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
DNA is currently a Follower in the organic co-movement group Gene Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.